Abstract:Background: Cardiac troponin is a complex protein consisting of the three subunits I, T and C located in heart muscle cells. When the heart muscle is damaged, it is released into the blood and can be detected. Cardiac troponin I (cTnI) is considered the most reliable and widely accepted test for detecting and confirming acute myocardial infarction. However, there is no current standardization between the commercial assays for cTnI quantification. Our work aims to create a measurement procedure that is traceable to the International System of Units for accurately measuring cardiac cTnI levels in serum samples from patients. Methods: The workflow begins with immobilizing anti-cTnI antibodies onto magnetic nanoparticles to form complexes. These complexes are used to isolate cTnI from serum. Next, trypsin is used to enzymatically digest the isolated cTnI. Finally, the measurement of multiple cTnI peptides is done simultaneously using isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS). Results: The maximum antibody immobilization was achieved by combining 1 mg of nanoparticles with 100 μg of antibody, resulting in an average of 59.2 ± 5.7 μg/mg of immobilized antibody. Subsequently, the anti-cTnI-magnetic nanoparticle complex was utilized to develop and validate a method for quantifying cTnI in human serum using ID-LC-MS/MS and a protein calibration approach. The analytical method was assessed regarding linearity and recovery. The developed method enables the quantification of cTnI from 0.7 to 24 μg/L (R > 0.996). The limit of quantification was 1.8 μg/L and the limit of detection was 0.6 μg/L. Intermediate precision was ≤ 9.6% and repeatability was 2.0-8.7% for all quality control materials. The accuracy of the analyzed quality control materials was between 90 and 110%. Total measurement uncertainties for target value assignment (n = 6) were found to be ≤ 12.5% for all levels. Conclusions: The analytical method demonstrated high analytical performance in accurately quantifying cardiac troponin I levels in human serum. The proposed analytical method has the potential to facilitate the harmonization of cTnI results between clinical laboratories, assign target values to secondary certified reference materials and support reliable measurement of cTnI.

Preparation of monoclonal antibodies against troponin I and development of one-step sandwich ELISA

Preparation of anti-cardiac troponin I monoclonal antibodies and their characterization with surface plasmon resonance biosensor

[Development, Identification and Application of 33 Monoclonal Antibodies Against Cardiac Troponin T].

Preparation and Characterization of Monoclonal Antibodies to Penicillin

Establishment of chemiluminescence enzyme immunoassay for detecting human cardiac troponin I

A Novel Sandwich Immunosensing Method for Measuring Cardiac Troponin I in Sera.

Two Desired Epitopes of Ctni Benefit for Preparation of Standardized Monoclonal Antibodies.

Separation and Purification of Human Cardiac Troponin I (ctn I)

Expression of cTnI Specific Antigen Sites and Antibodies Detection

Development of a simple enzyme-linked hybrid-sandwich assay for sensitive detection of cardiac troponin I

Development of a Low Density Colorimetric Protein Array for Cardiac Troponin I Detection

Establishment and Identification of Hybridoma Cell Lines Secreting Anti-human Myocardial Troponin T Antibody

Extraction and Purification of Human Cardiac Troponin I by Affinity Chromatography

Antigen Design in Production of Anti-Human Cardiac Troponin Ⅰ Monoclonal Antibody

The Impact of Antibody Selection on the Detection of Cardiac Troponin I.

Preparation and Identification of Monoclonal Antibody Against Cytolysin of Vibrio Vulnificus

Determination of affinities and antigenic epitopes of bovine cardiac troponin I (cTnI) with monoclonal antibodies by surface plasmon resonance biosensor.

Immunosensor for rapid detection of human cardiac troponin I, a biomarker for myocardial infarction

Development of an ID-LC-MS/MS method using targeted proteomics for quantifying cardiac troponin I in human serum

Fouling-Free Electrochemical Strategy based on Vertically-aligned Peptide Layer for Cardiac Troponin I Sensitive Detection in Human Serum

Aptamer-Based Fluorescent Assay for Sensitive Detection of Cardiac Troponin I